Bausch Health Companies Inc. (NYSE:BHC) Q4 2022 Earnings Conference Call February 23, 2023 8:00 AM ET
Company Participants
Thomas Appio - Chief Executive Officer
Tom Vadaketh - Chief Financial Officer
Conference Call Participants
Georgi Yordanov - Cowen and Company
Douglas Miehm - RBC Capital Markets
Glen Santangelo - Jefferies
David Amsellem - Piper Sandler
Jason Gerberry - Bank of America
Gary Nachman - BMO
Umer Raffat - Evercore ISI
Operator
Good morning, and welcome to Bausch Health's Fourth Quarter 2022 Earnings Conference Call. At this time, all participants have been placed on a listen-only mode. And we will open the floor for your questions and comments after the presentation. [Operator Instructions]
It is now my pleasure to turn the floor over to Judy DiClemente [ph]. Judy, the floor is yours.
Unidentified Company Representative
Thank you, Tom. Good morning, and welcome to Bausch Health's fourth quarter 2022 earnings conference call. This is Judy DiClemente, Investor Relations for Bausch Health. Participating in today's call are Thomas Appio, Chief Executive Officer of Bausch Health; and Tom Vadaketh, Chief Financial Officer.
Before we begin, I'd like to remind you that our presentation today contains forward-looking information. We would ask you to take a moment to read the forward-looking statements at the beginning of this presentation. Our actual results may vary materially from those expressed or implied in our forward-looking statements, and you should not place undue reliance on any forward-looking statements. Please refer to our SEC filings and filings with the Canadian securities administrators for a list of some of the factors that could cause our actual results to differ materially from our expectations.
We use non-GAAP financial measures to help investors understand our ongoing business performance. Non-GAAP financial measures may not be comparable to similarly titled measures used by other companies and should be considered along with, but not as an alternative to, measures calculated in accordance with GAAP. You will find reconciliations to our non-GAAP measures in the appendix of this presentation which is available on Bausch Health's Investor Relations website.
Finally, the financial guidance in this presentation is effective as of today only. We do not undertake any obligation to update guidance. Our discussion today will focus on Bausch Health, excluding P& L. However, we will briefly comment on Bausch + Lomb results announced yesterday. We will refer to year-over-year comparisons with the same period last year, unless otherwise noted. For the benefit of those who may be listening to the replay or archived webcast, this call was held and recorded on February 23rd, 2023.